Cannabis companies continue to look for ways to raise capital and customer counts.
Here are some of the key headlines from this past week:
- GB Sciences building cash reserves for potential FDA trials
- Organigram and Cresco announce stock sale programs
- WeedMD mixes acquisition, advocacy
- Akerna acquisition details
- Investor Intelligence Conference and MJBizCon Next Week!